Granuloma faciale treated with topical dapsone: A case report

Olubukola Babalola, Jessica Zhang, Arni Kristjansson, Diane Whitaker-Worth, Meagen McCusker*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)


Granuloma faciale (GF) is an unusual, treatment-resistant skin disorder that commonly affects the face. Several medical and surgical interventions are available that offer varying degrees of benefit. Both the condition and the treatment modalities can lead to significant disfigurement. The use of oral dapsone in the treatment of GF has been described in the literature, but there are no reports, to our knowledge, of the use of topical dapsone 5% gel (Aczone; Allergan Inc, Irvine, CA). We present a case of a patient with GF on the nasal tip successfully treated with topical dapsone.

Original languageEnglish
JournalDermatology Online Journal
Issue number8
Publication statusPublished - 2014

Other keywords

  • Dapsone
  • GF
  • Granuloma faciale
  • Therapy
  • Topical treatment


Dive into the research topics of 'Granuloma faciale treated with topical dapsone: A case report'. Together they form a unique fingerprint.

Cite this